Improving Skin Hydration and Elasticity: In addition to collagen, hyaluronic acid is another key component of healthy skin
The exact dose, frequency, and cycle length we use at Perfect B is broken down in our dedicated MOTS-c dosage and injection protocol guide covering reconstitution, timing, and cycle structure
Nausea, vomiting, diarrhea, constipation, fatigue, dizziness, and abdominal discomfort are recognized during GLP-1-based treatment and should not automatically be labeled as detox symptoms
Increased concentrations of iron and isoferritins in the lower respiratory tract of patients with stable cystic fibrosis
Tirzepatide (Mounjaro/Zepbound) Timeline Phase 3 trials began: 2019 (SURPASS program for diabetes) FDA approval (Mounjaro for diabetes): May 2022 Commercial availability: June 2022, initial supply constraints Zepbound (obesity indication) Phase 3: 2020-2022 (SURMOUNT program) Zepbound FDA approval: November 2023 Zepbound commercial launch: December 2023, immediate shortages Stable widespread availability: Still not fully stable as of early 2026
Been a member for 1.5 years
